Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 17,995 | 7,569 | 7,459 | 9,638 | 12,498 |
| Cost of Goods | 10,016 | 4,701 | 3,511 | 5,898 | 4,484 |
| Gross Profit | 7,979 | 2,868 | 3,948 | 3,739 | 8,014 |
| Operating Expenses | 10,280 | 12,727 | 13,510 | 11,994 | 16,815 |
| Operating Income | -2,285 | -9,159 | -9,051 | -7,356 | -8,317 |
| Interest Expense | 356 | 369 | 336 | 238 | 281 |
| Other Income | 403 | -427 | 4,668 | 9,538 | 7,394 |
| Pre-tax Income | -2,238 | -9,955 | -4,719 | 1,944 | -1,204 |
| Income Tax | 2 | -676 | -1,046 | -1,868 | -521 |
| Net Income Continuous | -2,240 | -9,279 | -3,673 | 3,811 | -683 |
| Net Income | $-2,240 | $-9,279 | $-3,673 | $3,811 | $-683 |
| EPS Basic Total Ops | 0.00 | -0.01 | 0.00 | 0.03 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-775 | $-7,902 | $-8,055 | $-6,641 | $-7,650 |